Pamela Divack is Senior Analyst with Advisory Board's Life Sciences and Health Care Ecosystem division. Her work focuses on conducting research and developing interactive experiences to support executives at pharmaceutical and medical device companies, as well as to foster cross-industry collaboration between payers, providers, life sciences, and other health care stakeholders.
Her recent research has focused on topics including: real-world evidence, clinical trial innovation, health technology assessment (HTA) evaluation processes, health plan and provider decision making, life sciences medical affairs strategy, medical “value,” Covid-19 vaccine development and rollout, and the impact of Covid-19 on life sciences strategy and operations.
Pamela graduated from Cornell University's College of Arts and Sciences with a B.A. in Biology and Society and minor in Business.